A Phase 2 study of the efficacy and safety of PH-797804 taken for 12 weeks in adults with COPD taking a background of salmeterol/fluticasone combination

Update Il y a 4 ans
Reference: EUCTR2010-024219-15

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the efficacy and safety/tolerability of 12 weeks administration of PH-797804 in adults with moderate to severe COPD (GOLD stage II/III) on a background of salmeterol xinafoate/fluticasone propionate combination.


Inclusion criteria

  • Chronic Obstructive Pulmonary Disease (COPD)